Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries


Journal article


Chengsheng Ju, W. Lau, J. Hayes, D. Osborn, K. Man, E. Chan, I. Wong, Li Wei
Alzheimer's & dementia, 2021

Semantic Scholar DOI PubMedCentral PubMed
Cite

Cite

APA   Click to copy
Ju, C., Lau, W., Hayes, J., Osborn, D., Man, K., Chan, E., … Wei, L. (2021). Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries. Alzheimer's &Amp; Dementia.


Chicago/Turabian   Click to copy
Ju, Chengsheng, W. Lau, J. Hayes, D. Osborn, K. Man, E. Chan, I. Wong, and Li Wei. “Impact of the COVID‐19 Pandemic on Use of Anti‐Dementia Medications in 34 European and North American Countries.” Alzheimer's & dementia (2021).


MLA   Click to copy
Ju, Chengsheng, et al. “Impact of the COVID‐19 Pandemic on Use of Anti‐Dementia Medications in 34 European and North American Countries.” Alzheimer's &Amp; Dementia, 2021.


BibTeX   Click to copy

@article{chengsheng2021a,
  title = {Impact of the COVID‐19 pandemic on use of anti‐dementia medications in 34 European and North American countries},
  year = {2021},
  journal = {Alzheimer's & dementia},
  author = {Ju, Chengsheng and Lau, W. and Hayes, J. and Osborn, D. and Man, K. and Chan, E. and Wong, I. and Wei, Li}
}

Abstract

The impact of the COVID‐19 pandemic on the global use of anti‐dementia medication is unknown. We aimed to determine the changes of anti‐dementia medication use in Europe (EU) and North America (NA) during the pandemic.


Share



Follow this website


You need to create an Owlstown account to follow this website.


Sign up

Already an Owlstown member?

Log in